Multiparameter Monitors in Delaware

Med Storm Innovation AS develops the PainSensor, an objective nociception monitoring device designed for perioperative anesthesia management and pain assessment. The PainSensor measures skin conductance algesimetry (SCA) to quantify nociceptive response in real time, providing indices for pain perception, awakening depth in unconscious patients, nerve block efficacy, and withdrawal symptoms. The device is based on skin sympathetic nerve activity and acetylcholine signaling, operating independently of temperature, neuromuscular blockers, alpha-2 agonists, epinephrine, beta-blockers, hypoxia, blood volume changes, and perioperative anxiety in conscious patients. Clinical validation spans over 80 peer-reviewed studies demonstrating rapid index response (within seconds) with low inter-individual variation. The PainSensor software integrates with existing multiparameter monitors from Philips and Masimo; Mindray and Draeger integration are in development. The company has received CE Mark (MDR 2017/745 Class IIa), ISO 13485 certification, and has an FDA approval pathway underway. Med Storm has received recognition including Eurostars grants (top 10% of applications), the Society for Technology in Anesthesia award for clinical utility, and Innovation Norway entrepreneur and AstraZeneca pain research prizes. The technology addresses the significant clinical need for objective, quantitative pain monitoring to optimize anesthesia dosing and reduce opioid-related complications.

Timpel Medical develops and markets the ENLIGHT 2100, a bedside electrical impedance tomography (EIT) system for real-time, non-invasive ventilation monitoring and precision mechanical ventilation guidance. The system uses high-frequency, low-intensity electrical signals transmitted through electrodes embedded in a chest strap to generate live dynamic images of lung ventilation and perfusion (V/Q) distribution without radiation or patient transport. Core applications include ICU ventilator management, neonatal and pediatric respiratory support, PEEP titration, detection of ventilator asynchrony, and weaning protocols from intubation to extubation. The ENLIGHT 2100 integrates clinical decision-support tools: Ventilation Screen, PEEP Titration, Trends Screen, Asynchrony Tool, V/Q Tool, and Neonatal Monitoring. The system operates bedside, is operator-independent, and suitable for adult, pediatric, and neonatal patients. Timpel is privately held and backed by FinHealth (Brazilian private equity/venture capital), FAPESP, and FINEP (Brazilian public research funding agencies). The company maintains offices in the Netherlands (Eindhoven), Brazil (São Paulo), and the USA (San Diego). Timpel emphasizes precision medicine, heterogeneous lung physiology adaptation, objective-driven ventilation strategies, and early detection of pulmonary complications before clinical manifestation.

hinlab Inc. is a Palo Alto-based healthtech company developing FDA-cleared wearable monitoring cuffs for clinical-grade vital signs measurement in hospital, home, and clinical trial settings. The company manufactures two primary product lines: hinscope (adult cuff) and Gabi (pediatric cuff), both wireless, waterproof devices that capture blood pressure, pulse rate, and SpO₂ automatically without patient intervention. Devices integrate with cloud-based platforms for real-time data synchronization, alert generation, and clinician dashboards on mobile devices and central monitoring stations. hinlab targets emergency departments, post-surgical recovery units, remote patient monitoring programs, sleep diagnostics (pediatric and adult), and decentralized clinical research. The Gabi platform, acquired in August 2025, enables home-based sleep study analysis for children aged 28 days to 12 years. Both devices are FDA-cleared medical devices, clinically validated, and designed to detect respiratory and physiological deterioration early (addressing the clinical gap of 90% undetected respiratory crashes on general wards). hinlab is part of Stanford's StartX accelerator and holds ISO certification. Products are available by prescription or for healthcare professional purchase only and are HSA/FSA eligible. The company serves major hospital systems and research institutions including Cleveland Clinic, UCSF, and others.